PFM Health Sciences’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-328,763
| Closed | -$25.6M | – | 70 |
|
|
2024
Q4 | $25.6M | Buy |
+328,763
| New | +$25.6M | 1.58% | 15 |
|
|
2024
Q3 | – | Sell |
-231,007
| Closed | -$26.2M | – | 77 |
|
|
2024
Q2 | $26.2M | Buy |
231,007
+75,129
| +48% | +$8.52M | 1.3% | 26 |
|
|
2024
Q1 | $21.6M | Buy |
+155,878
| New | +$21.6M | 1.02% | 31 |
|
|
2023
Q4 | – | Sell |
-318,769
| Closed | -$29.7M | – | 69 |
|
|
2023
Q3 | $29.7M | Sell |
318,769
-55,709
| -15% | -$5.2M | 1.4% | 32 |
|
|
2023
Q2 | $48.1M | Sell |
374,478
-49,338
| -12% | -$6.34M | 1.87% | 19 |
|
|
2023
Q1 | $49.2M | Buy |
423,816
+288,351
| +213% | +$33.5M | 2.17% | 11 |
|
|
2022
Q4 | $15.3M | Buy |
+135,465
| New | +$15.3M | 0.55% | 52 |
|
|
2022
Q2 | – | Sell |
-148,084
| Closed | -$18.9M | – | 78 |
|
|
2022
Q1 | $18.9M | Buy |
148,084
+130,208
| +728% | +$16.7M | 0.71% | 47 |
|
|
2021
Q4 | $2.4M | Sell |
17,876
-52,164
| -74% | -$7M | 0.08% | 67 |
|
|
2021
Q3 | $9.58M | Buy |
+70,040
| New | +$9.58M | 0.28% | 57 |
|
|
2021
Q2 | – | Sell |
-225,768
| Closed | -$20.3M | – | 81 |
|
|
2021
Q1 | $20.3M | Buy |
+225,768
| New | +$20.3M | 0.62% | 48 |
|
|
2019
Q4 | – | Sell |
-1,712,968
| Closed | -$63.9M | – | 59 |
|
|
2019
Q3 | $63.9M | Buy |
1,712,968
+66,184
| +4% | +$2.47M | 1.89% | 16 |
|
|
2019
Q2 | $61.7M | Buy |
+1,646,784
| New | +$61.7M | 1.17% | 23 |
|
|
2018
Q4 | – | Sell |
-1,221,216
| Closed | -$43.7M | – | 98 |
|
|
2018
Q3 | $43.7M | Buy |
+1,221,216
| New | +$43.7M | 0.64% | 54 |
|
|
2018
Q2 | – | Sell |
-2,056,656
| Closed | -$38.1M | – | 108 |
|
|
2018
Q1 | $38.1M | Buy |
+2,056,656
| New | +$38.1M | 0.77% | 51 |
|
|
2016
Q2 | – | Sell |
-682,140
| Closed | -$11.6M | – | 73 |
|
|
2016
Q1 | $11.6M | Sell |
682,140
-22,012
| -3% | -$374K | 0.36% | 58 |
|
|
2015
Q4 | $14.4M | Buy |
+704,152
| New | +$14.4M | 0.44% | 50 |
|